Feras Abdulaziz Alfraih
Dr. Feras Abdulaziz Alfraih, MBBS, MBA, FACHE, is a Saudi physician and healthcare executive specializing in Adult Hematology and Hematopoietic Stem Cell Transplantation. He currently serves as Executive Director of the Cancer Centre of Excellence at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, where he has also worked as a consultant in Adult Hematology and Stem Cell Transplantation since 2014. He is an Associate Professor of Medicine at Alfaisal University and founded the hospital’s Alternate Stem Cell Donor Transplantation Program.
His professional background combines advanced medical expertise with healthcare management and institutional leadership. He completed fellowships in Adult Hematology and Allogeneic Stem Cell Transplantation at Princess Margaret Cancer Centre in Toronto, following his Saudi Hematology Fellowship and Internal Medicine Residency at KFSH&RC. He also holds an MBA in International Healthcare Management from Frankfurt School of Finance and Management and is a Fellow of the American College of Healthcare Executives.
In addition to his clinical responsibilities, Dr. Alfraih has held several senior leadership positions at KFSH&RC, including Deputy Chief Medical Officer, Director of Patient Flow and Command Centre, and Executive Director of the Clinical Services Centre of Excellence. He has led initiatives related to clinical governance, healthcare command and control, medical staff bylaws, patient experience, digital transformation and strategic healthcare management. He also serves as President of the Saudi Society for Blood Disorders and President of the International Society of Hematology, while serving as President-Elect of the MENA Chapter of the American College for Healthcare Executives.
Dr. Alfraih has an extensive research and academic record, with numerous publications in hematology, leukemia, stem cell transplantation, cancer care and healthcare systems. His recent work includes research on CAR-T cell therapy, acute lymphoblastic leukemia, stem cell transplantation outcomes and cancer management in the Middle East. He has also contributed to international and regional consensus work in hematology and transplantation.
Beyond medicine and research, he is actively involved in public education and awareness. He founded an Arabic hematology educational platform and has organized and contributed to awareness initiatives related to stem cell donation, blood cancers, leukemia, thrombosis and thalassemia. His professional achievements have been recognized through several awards, including the Princess Adala Bint Abdullah Award in 2025 and the Global Excellence Award in Technology from the Project Management Institute in 2023.